The Improved Delivery to Breast Cancer Based on a Novel Nanocarrier Modified with High-Affinity Peptides Discovered by Phage Display
Author:
Affiliation:
1. State Key Laboratory of Natural and Biomimetic Drugs; School of Pharmaceutical Sciences; Peking University Health Science Center; Beijing 100191 China
2. School of Life Science and Medicine; Dalian University of Technology; Liaoning 124221 China
Funder
973 Program of China
National Natural Science Foundation of China
Publisher
Wiley
Subject
Pharmaceutical Science,Biomedical Engineering,Biomaterials
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/adhm.201800269/fullpdf
Reference47 articles.
1. HER2-Orientated Therapy in Early and Metastatic Breast Cancer
2. Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
3. Nanoparticle therapeutics: an emerging treatment modality for cancer
4. EPR-effect: utilizing size-dependent nanoparticle delivery to solid tumors
5. Lipid composition has significant effect on targeted drug delivery properties of NGR-modified liposomes
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Applications of the phage display technology in molecular biology, biotechnology and medicine;Critical Reviews in Microbiology;2023-06-04
2. Engineered M13 phage as a novel therapeutic bionanomaterial for clinical applications: From tissue regeneration to cancer therapy;Materials Today Bio;2023-06
3. Screening of peptide selectively recognizing prostate-specific antigen and its application in detecting total prostate-specific antigen;Sensors and Actuators B: Chemical;2022-09
4. Targeted delivery of doxorubicin by Thermo/pH-responsive magnetic nanoparticles in a rat model of breast cancer;Toxicology and Applied Pharmacology;2022-07
5. Specific heptapeptide screened from pIII phage display library for sensitive enzyme-linked chemiluminescence immunoassay of vascular endothelial growth factor;Sensors and Actuators B: Chemical;2021-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3